Cigna Group (NYSE: CI) disclosed in a SEC 8-K filing dated April 30, 2026, that Q1 revenue reached $68.5 billion, representing 5% growth compared to the prior-year quarter.
Earnings at a Glance
Q1 revenue increased 5% from $65.5 billion in the prior-year period. Growth was driven primarily by Evernos Health Services. Results were partially offset by impacts related to HCSC (Blue Cross Blue Shield Association entities) transaction. Adjusted operating income per share (excluding one-time items under non-GAAP accounting) reached $7.79, up 15.6% from $6.74 in the prior-year quarter.
- Revenue: $68.5 billion, +5% YoY
- Net income attributable to shareholders (GAAP): $1.654 billion; EPS $6.26
- Adjusted operating EPS: $7.79, exceeding consensus estimate by $0.18
- Total adjusted operating income: $2.058 billion, +12% YoY
- SG&A ratio: 5.4%, improved from 6.4% in prior-year quarter
Forward Guidance
Cigna raised its full-year 2026 adjusted operating EPS guidance to at least $30.35. CEO and Chairman David Cordani stated: "Strong Q1 results reflect rigorous execution, deliberate business restructuring, and continued focus on innovation."
Market Reaction
Stock price movement figures were not disclosed. Financial data providers GuruFocus and StreetInsider reported that revenue exceeded consensus expectations, with adjusted operating EPS also $0.18 above consensus. StockTitan noted that "Following a $68.5 billion quarter, Cigna raised its 2026 earnings target."
Segment Performance
- Evernos Health Services – Pharmacy Benefit Services: Adjusted revenue $33.0 billion, up 11% from $29.7 billion in prior year
- Evernos Health Services – Specialty and Care Services: Adjusted revenue $25.4 billion, up 6% from $23.9 billion in prior year
- Medical customers: 18.33 million, +1% from end of prior quarter
- Pharmacy services customers: 121.02 million, -2% from end of prior quarter
- Total customer relationships: 185.47 million, -2% from end of prior quarter
This article was auto-generated based on SEC 8-K filings and third-party reporting and aims to deliver key data shortly after disclosure. Investors are advised to review official company filings before making trading decisions.
